HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel phycobiliprotein alleviates allergic airway inflammation by modulating immune responses.

AbstractRATIONALE:
it has been claimed that phycocyanin exhibits pharmaceutical functions in inhibiting histamine release and leukotriene biosynthesis. In allergic asthma, these inflammatory mediators are crucial for disease progression.
OBJECTIVES:
the aim of this study was to evaluate the therapeutic potential of R-phycocyanin (R-PC) against allergic airway inflammation.
METHODS:
mouse bone marrow-derived dendritic cells (BMDCs) were used to evaluate the immunomodulatory functions of R-PC. In addition, an airway inflammatory model was used to evaluate the therapeutic potential of R-PC.
MEASUREMENTS AND MAIN RESULTS:
R-PC treatment resulted in a decrease of endocytosis, increase of costimulatory molecule expression, and enhancement of interleukin-12 production in mouse BMDCs. Moreover, R-PC-treated cultured dendritic cells were able to promote CD4(+) T-cell stimulatory capacity and increase interferon-γ expression in CD4(+) T cells. Intraperitoneal administration of R-PC suppressed ovalbumin (OVA)-induced airway hyperresponsiveness, serum levels of OVA-specific IgE and IgG1, eosinophil infiltration, Th2 cytokine levels, and eotaxin in bronchoalveolar lavage fluid of mice. Antibody against Toll-like receptor-4 was able to inhibit R-PC-induced IL-12 p70 production. Moreover, inhibition of nuclear factor-κB (NF-κB) by helenalin and inhibition of the JNK pathway by JNK inhibitor II inhibited R-PC-induced IL-12 p70 production. Western blotting and electrophoretic mobility shift assays showed that R-PC augmented phosphorylation of the inhibitors of NF-κB and inhibitors of NF-κB kinase and facilitated NF-κB activity.
CONCLUSIONS:
our data demonstrated that R-PC promoted activation and maturation of cultured dendritic cells and skewed the immunological function toward Th1 activity. Therefore, R-PC may have potential in regulating immune responses and application in reducing allergic asthma.
AuthorsChun-Jung Chang, Yao-Hsu Yang, Yu-Chih Liang, Chiao-Juno Chiu, Kuan-Hua Chu, Hung-Non Chou, Bor-Luen Chiang
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 183 Issue 1 Pg. 15-25 (Jan 01 2011) ISSN: 1535-4970 [Electronic] United States
PMID20709826 (Publication Type: Journal Article)
Chemical References
  • Leukotrienes
  • Phycobiliproteins
Topics
  • Animals
  • Asthma (drug therapy, immunology, metabolism)
  • Blotting, Western
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Histamine Release (drug effects)
  • Immunity, Innate
  • Inflammation (immunology, metabolism, prevention & control)
  • Leukotrienes (biosynthesis)
  • Mice
  • Mice, Inbred BALB C
  • Phycobiliproteins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: